MannKind Corp (MNKD) Stock Price, Quote, News & History

MNKDNASDAQ
$3.75
-0.04-1.06%
At close: Sep 11, 5:00 PM EST
$3.75
N/A
After Hours: Sep 11, 5:12 PM EST

MannKind (MNKD) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-8.05M
Investing Cash Flow (TTM)
-280.39M
Financing Cash Flow (TTM)
284.37M
Free Cash Flow (TTM)
-18.14M
Capital Expenditure (TTM)
-10.08M
Net Change in Cash (TTM)
-4.07M

Analyst Trends and Forecast

2
Apr
3
May
1
Jul
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.43B
PE Ratio (TTM)
-
PE Ratio (FWD)
29.24
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.01
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-3.95%
Earnings Yield % (FWD)
3.42%
EV / EBITDA (TTM)
70.77
Price / EBITDA (TTM)
58.26
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.21

Company Debt

Total Debt
$319.08M
LT Debt
$319.08M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$35.50M
Total Cash
$52.93M
Debt to Equity
-
Issuance of Debt (TTM)
$289.50M
Repayment of Debt (TTM)
-$35.50M

Key Statistics

Open
$3.83
Close
$3.75
Volume / Avg.
2.47M / 4.53M
Day Range
$3.73 - $3.85
52 Wk Range
2.23 - 6.51
Market Cap
$1.21B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
8.37%
Days to Cover
8.48

About

Sector
Health Care
Industry
Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy MannKind (MNKD) stock?

A

You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for MannKind (MNKD) stock?

A

MannKind has a consensus price target of $9.34.

Q

What is the current price for MannKind (MNKD)?

A

The stock price for MannKind (NASDAQ: MNKD) is $3.75 last updated September 11, 2026 at 5:12 PM EDT.

Q

Does MannKind (MNKD) pay a dividend?

A

There are no upcoming dividends for MannKind.

Q

When is MannKind (NASDAQ:MNKD) reporting earnings?

A

MannKind does not have any upcoming earnings scheduled.

Q

Is MannKind (MNKD) going to split?

A

There is no upcoming split for MannKind.

Q

What sector and industry does MannKind (MNKD) operate in?

A

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.